Dermaxir ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.4% 7.8% 5.6% 10.2% 13.8%  
Credit score (0-100)  40 33 42 25 16  
Credit rating  BBB BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6

Net sales  0 0 0 0 0  
Gross profit  311 441 646 803 117  
EBITDA  231 -97.4 208 563 117  
EBIT  231 -97.4 208 563 117  
Pre-tax profit (PTP)  231.1 -95.7 212.0 566.7 104.4  
Net earnings  180.3 -74.7 141.5 441.0 81.1  
Pre-tax profit without non-rec. items  231 -95.7 212 567 104  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  224 149 290 581 222  
Interest-bearing liabilities  144 97.2 41.6 190 204  
Balance sheet total (assets)  527 434 544 1,122 591  

Net Debt  -96.1 10.7 -310 -895 -341  
 
See the entire balance sheet

Volume 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  311 441 646 803 117  
Gross profit growth  0.0% 41.6% 46.4% 24.4% -85.4%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  527 434 544 1,122 591  
Balance sheet change%  0.0% -17.6% 25.3% 106.2% -47.3%  
Added value  230.7 -97.4 207.7 563.4 116.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 1.0 2.0 3.0  

Profitability 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  74.1% -22.1% 32.2% 70.2% 99.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  44.7% -19.2% 43.6% 68.0% 13.9%  
ROI %  64.1% -30.1% 73.8% 102.7% 19.8%  
ROE %  80.7% -40.1% 64.5% 101.2% 20.2%  

Solidity 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
Equity ratio %  42.4% 34.3% 53.3% 52.5% 37.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -41.6% -10.9% -149.3% -158.9% -292.7%  
Gearing %  64.6% 65.3% 14.3% 32.7% 91.8%  
Net interest  0 0 0 0 0  
Financing costs %  6.4% 2.8% 1.7% 0.0% 7.3%  

Liquidity 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
Quick Ratio  1.7 1.5 2.6 2.8 1.7  
Current Ratio  1.7 1.5 2.6 2.7 1.7  
Cash and cash equivalent  240.5 86.5 351.8 1,085.5 545.6  

Capital use efficiency 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  223.5 151.5 337.1 706.0 245.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2017/6
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
Net sales / employee  0 0 0 0 0  
Added value / employee  231 -97 208 563 117  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  231 -97 208 563 117  
EBIT / employee  231 -97 208 563 117  
Net earnings / employee  180 -75 142 441 81